Efficacy of Debridement Alone Versus Debridement Combined with Topical Antifungal Nail Lacquer for the Treatment of Pedal Onychomycosis: A Randomized, Controlled Trial

Journal of Foot and Ankle Surgery

Volumn 48, Issue 3, 2009, Pages 294-308

  Malay, D Scot ^a   Yi, Sang ^a   Borowsky, Pamela ^a   Downey, Michael S ^a   Mlodzienski, Alan J ^a  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

Bristol Foot Score; ciclopirox; dermatophyte; generalized estimation equation; quality of life; toe; yeast

Indexed keywords

CICLOPIROX; CICLOPIROXOLAMINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DISEASE ASSOCIATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAIL FOLD CUTANEOUS IRRITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN APPENDAGE DISEASE; TOENAIL ONYCHOMYCOSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTIFUNGAL AGENTS; DEBRIDEMENT; FEMALE; FOOT DERMATOSES; HUMANS; HYPERHIDROSIS; MALE; MIDDLE AGED; ONYCHOMYCOSIS; PYRIDONES; RISK FACTORS; SINGLE-BLIND METHOD; SMOKING; TIME FACTORS; TREATMENT OUTCOME; URBAN HEALTH SERVICES;

EID: 65449137038     PISSN: 10672516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jfas.2008.12.012     Document Type: Article

References (32)

1. Elewski B.E., and Charif M.A. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol 133 (1997) 1172-1173
2. Heikkila H., and Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 133 (1995) 699-703
3. Elewski B.E. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev 11 (1998) 415-429
4. Gupta A.K., Konnikov N., and MacDonald P. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 139 (1998) 665-671
5. Gupta A.K., Jain H.C., Lynde C.W., Macdonald P., Cooper E.A., and Summerbell R.C. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 43 2 Pt 1 (2000) 244-248
6. Markinson B.C., Monter S.I., and Cabrera G. Traditional approaches to treatment of onychomycosis. J Am Podiatr Med Assoc 87 12 (1997) 551-556
7. Diabetes Survey. Statistical results. Al Fisher Associates, Inc. J Am Podiatr Med Assoc 87 (1997) 575-582
8. McInnes B.D., and Dockery G.L. Surgical treatment of mycotic toenails. J Am Podiatr Med Assoc 87 (1997) 557-564
9. Joseph W.S. Oral treatment options for onychomycosis. J Am Podiatr Med Assoc 87 (1997) 520-529
10. Baran R., Hay R.J., and Garduno J.I. Review of antifungal therapy, part II: treatment rationale, including specific patient populations. J Dermatolog Treat 19 3 (2008) 168-175
11. Shemer A., Trau H., Davidovici B., Amichai B., and Grunwald M.H. Onychomycosis: rationalization of topical treatment. Isr Med Assoc J 10 6 (2008) 415-416
12. Shemer A., Nathansohn N., Kaplan B., and Trau H. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?. J Eur Acad Dermatol Venereol 22 3 (2008) 279-282
13. Bohn M., and Kraemer K.T. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. J Am Acad Dermatol 43 suppl 4 (2000) S57-S69
14. Gupta A.K., and Baran R. Ciclopirox nail lacquer solution 8% in the 21st century. J Am Acad Dermatol 43 suppl 4 (2000) S96-S102
15. Gupta A.K., Fleckman P., and Baran R. Ciclopirox nail lacquer solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol 43 suppl 4 (2000) S70-S80
16. Gupta A.K., and Joseph W.S. Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States. J Am Podiatr Med Assoc 90 10 (2000) 495-501
17. Sommer S., Sheehan-Dare R.A., Goodfield M.J., and Evans E.G. Prediction of outcome in the treatment of onychomycosis. Clin Exp Dermatol 28 4 (2003) 425-428
18. Avner S., Nir N., and Henri T. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. J Dermatolog Treat 16 5-6 (2005) 327-330
19. Edwards L.F., and Schott R.G. The daily rate of growth of toe nails. Ohio J Sci 37 2 (1937) 91-98
20. Johnson M., and Shuster S. Continuous formation of nail along the bed. Br J Dermatol 128 3 (1993) 277-280
21. Barnett S., Campbell R., and Harvey I. The Bristol foot score: developing a patient-based foot-health measure. J Am Podiatr Med Assoc 95 3 (2005) 264-272
22. Maldonado G., and Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 138 (1993) 923-936
23. Wang C.Y. Weighted normality-based estimator in correcting correlation coefficient estimation between incomplete nutrient measurements. Biometrics 56 1 (2000) 106-112
24. Schaubel D.E. Variance estimation for clustered recurrent event data with a small number of clusters. Stat Med 24 19 (2005) 3037-3051
25. Guo X., Pan W., Connett J.E., Hannan P.J., and French S.A. Small-sample performance of the robust score test and its modifications in generalized estimating equations. Stat Med 24 22 (2005) 3479-3495
26. Begaud B., Moride Y., Tubert-Bitter P., Chaslerie A., and Haramburu F. False-positives in spontaneous reporting: should we worry about them?. Br J Clin Pharmacol 38 (1994) 401-404
27. Penlac Prescribing Information, June 2003, Dermik Laboratories. Available at: http://products.sanofi-aventis.us/penlac/penlac.html. Accessed December 27, 2008.
28. Atherton D., and Mills K. What can be done to keep babies' skin healthy?. RCM Midwives 7 7 (2004) 288-290
29. Yosipovitch G., Tur E., Cohen O., and Rusecki Y. Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care 16 4 (1993) 560-563
30. McMullen D. Candida albicans and incontinence. Dermatol Nurs 3 1 (1991) 21-24
31. Weaver T.D., and Jespersen D.L. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine. Cutis 66 3 (2000) 211-212
32. Cabral A., Berger T.H., Middag-Broekman J.H., and Boon M.E. Unequivocal morphological diagnosis of fungi in morphologically abnormal nails. Histopathology 48 7 (2006) 862-867